Karen Pomeranz is an accomplished analyst with expertise in product development and oncology. She earned her Doctor of Philosophy in Molecular Medicine at Imperial College London, where she honed her analytical skills. After graduation, she worked as a Senior Business Insights Analyst at Decision Resources Group before transitioning to her current role as a Managing Analyst at Evaluate Ltd. Karen's background in molecular medicine has given her a deep understanding of the science behind drug development, while her experience as an analyst has taught her how to work with data to extract meaningful insights and drive business decisions.